News | Radiation Therapy | January 02, 2018

Water phantom system enables fast and seamless beam scanning

Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine

January 2, 2018 — IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian Halcyon radiation therapy system in Europe to go clinical, at the hospital UZ Leuven in Belgium, using IBA Dosimetry’s Blue Phantom water phantom system.

Prof. Tom Depuydt, head of physics at UZ Leuven, Belgium, said: “We are very happy to announce that we were able to deliver the first treatment fraction with the Varian Halcyon system on Oct. 2nd, within just 14 days of the machine’s installation. This was made possible by the fruitful collaboration of our physics team and IBA Dosimetry, and use of the Blue Phantom system to ensure fast and reliable acceptance of our new machine.”

The Blue Phantom system enables fast and seamless beam scanning workflows that are ideal for verification and annual quality assurance (QA) of the Varian Halcyon. Next to the compact design, the phantom’s conveniently accessible micro-leveling frame enables fast and precise system setup.

For more information: www.iba-worldwide.com


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
Subscribe Now